MedTrace Logo

Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients

NCT05801757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2024-08-13

No results posted yet for this study

Summary

To observe the sedative effect of continuous infusion of remidazolam in elderly patients undergoing colonoscopic polypectomy.

Conditions

  • Colon Disease

Interventions

DRUG

Remimazolam

Using two different doses of remidazolam for continuous pumping to maintain anesthetic effect

DRUG

Propofol

propofol 2-3mg/kg/h

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • aihua Du, Dr. · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05801757 on ClinicalTrials.gov